Abstract
Molly Stevens has long been driven by the hope that her research will change people’s lives. Toward the end of her PhD work in single-molecule biophysics, she heard a talk by Massachusetts Institute of Technology biomedical engineer Robert Langer on how the lives of young people with organ failure might be saved by future developments in regenerative medicine. That inspired Stevens to take the skills she had developed studying fundamental molecular mechanisms into a more applied direction. At Imperial College London, her large, interdisciplinary research group has been working on such bioengineering challenges for the past 15 years. As director of the Smart Materials Hub of the UK Regenerative Medicine Platform, a cross-university initiative, she is keen on integrating commercial, manufacturing, and regulatory expertise so that advances in materials technology actually reach patients. In addition to developing biomaterials, Stevens’s group develops low-cost diagnostics for use in resource-limited countries. Rachel Brazil
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
